Street; Stephen Derek Albert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Street; Stephen Derek Albert.The latest application filed is for "treatment of male sexual dysfunction".

Company Profile

0.8.8

Street; Stephen Derek Albert - Sandwich GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Male Sexual Dysfunction App 20150072995 - Naylor; Alasdair Mark ; et al.	2015-03-12
Treatment of Male Sexual Dysfunction App 20130121923 - Naylor; Alasdair Mark ; et al.	2013-05-16
Treatment of Male Sexual Dysfunction App 20110107442 - Naylor; Alasdair Mark ; et al.	2011-05-05
Pharmaceutically Active Compounds App 20100035891 - Bunnage; Mark Edward ; et al.	2010-02-11
Treatment Of Male Sexual Dysfunction App 20090175793 - Naylor; Alasdair Mark ; et al.	2009-07-09
Process for preparing pharmaceutically active compounds Grant 7,176,311 - Bunnage , et al. February 13, 2	2007-02-13
Pharmaceutically Active Compounds App 20060293347 - Bunnage; Mark Edward ; et al.	2006-12-28
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction Grant 6,916,927 - Bunnage , et al. July 12, 2	2005-07-12
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction App 20040180944 - Bunnage, Mark Edward ; et al.	2004-09-16
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'--monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction Grant 6,723,719 - Bunnage , et al. April 20, 2	2004-04-20
Pharmaceutically active compounds Grant 6,677,335 - Bunnage , et al. January 13, 2	2004-01-13
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction Grant 6,670,366 - Bunnage , et al. December 30, 2	2003-12-30
Treatment of male sexual dysfunction App 20030229001 - Naylor, Alasdair Mark ; et al.	2003-12-11
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction Grant 6,458,951 - Bunnage , et al. October 1, 2	2002-10-01
Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction Grant 6,333,330 - Bunnage , et al. December 25, 2	2001-12-25
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction Grant 6,251,904 - Bunnage , et al. June 26, 2	2001-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.